Sunshine Lake Pharma
Sunshine Lake Pharma (Guangdong East Sunshine Pharmaceutical Co., Ltd., also known as HEC Pharm) is a Chinese pharmaceutical company established in 2003 and part of the Dongyangguang (HEC) Group. It engages in drug research, development, production, and commercialization across innovative drugs, improved formulations, generics, and biosimilars, focused on infections, chronic diseases, and oncology. Notable products include oseltamivir phosphate (influenza), sofosbuvir-based hepatitis C therapy, and insulin glargine (diabetes). It is a manufacturer with no public developer or API surface. Surfaced as a portfolio company of idg-capital and added to the API Evangelist network.
Sunshine Lake Pharma is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Pharmaceuticals, Biotechnology, and Life Sciences.
Kin Score
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| Clinical Trial Sponsors (drug pipelines) | regulated | 41.1 (thin) | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
Resources
Company 1
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.